You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国抗体-B(03681.HK)拟向主要股东海药发行1亿港元可换股债 初步换股价溢价25%
格隆汇 12-22 23:03

格隆汇 12 月 22日丨中国抗体-B(03681.HK)公布,于2020年12月22日,公司拟向投资者海药国际集团发行本金总额为1亿港元的可换股债券,年利率4.95%。初步换股价为每股5.0港元,较12月22日收市价溢价约25%。

在按初始换股价全面转换可换股债券的情况下,将发行2000万股股份,相当经扩大后的已发行股份约1.95%。

据悉,投资者为公司主要股东海药的全资附属公司,持有1.59亿股股份,约占公司股权的15.79%。

公告称,建议发行可换股债券的所得款项(在扣除与其有关的所有估计开支后)预期约为9889.91万港元。公司拟将可换股债券的所得款项全部用于临床成本、建设位于中国的综合基地、研发及商业化公司产品或在研药物以及补充营运资金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account